Nathan Seppa has been the biomedical writer at Science News since 1997. Previously, he worked at the Wisconsin State Journal, a daily newspaper in Madison, where he inaugurated the science beat. In the 1980s, he covered energy and economics for the Dow Jones News Service in the Wall Street Journal's Washington Bureau. In the 1970s, Seppa served as a public health volunteer in the Peace Corps in Zaire, now Congo. He hails from the Upper Peninsula of Michigan, where he worked as a miner and gravedigger to pay his way through college. He has a B.S. in Sociology and a M.A. in Journalism. Nathan speaks French and knows enough Swahili to get out of a tight spot.
Nathan Seppa's Articles
- News in BriefPatients stayed on track better with a "polypill" than with three medications.
- NewsA urine test for an immune protein might tell doctors whether a patient is headed for trouble.
- NewsTests in mice reveal that allergens can trigger inflammation by cleaving a clotting protein.
- FeatureTalking while driving poses dangers that people seem unable to see.
- NewsA series of shots enables volunteers to fend off a live infection by the disease-causing parasite.
- News in BriefElderly people with elevated blood glucose levels are more apt to develop dementia, whether or not they have diabetes.
- NewsChildren at risk of type 1 diabetes are better off waiting until 4 months of age to consume solid foods.
- NewsPeople in Bangladesh have genetic variations that might defend against the disease.
- News in BriefFindings in a small group of patients hint that a DNA-based therapy might work, but the effects fade after treatment stops.
- News in BriefRecently immunized people are not at an increased risk of developing Guillain-Barre syndrome, a nerve-damaging condition.